Actively Recruiting
Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy
Led by West China Hospital · Updated on 2024-05-09
524
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a further observation and follow-up of the patients enrolled in the registration number NCT06341270 to further evaluate the efficacy of TEAS on postoperative chronic pain, quality of life and survival rate in patients undergoing hepatectomy.
CONDITIONS
Official Title
Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 80 years old
- ASA physical status class I to III
- Scheduled for elective hepatectomy
You will not qualify if you...
- History of epilepsy
- Rash or local infection over the acupoint stimulation skin area
- Pregnancy or breastfeeding
- Mental retardation, psychiatric, or neurological disease
- Inability to understand the numeric rating scale (NRS)
- Implanted cardiac pacemaker, cardioverter, or defibrillator
- Chronic opioid use
- Metastases in other organs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
West China Hospital
Chengdu, China, 610041
Actively Recruiting
Research Team
C
Chunling Jiang, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here